Event

Zi Lin

MD
Beijing Novartis Pharma Co. Ltd.

Jing Yang

MD
Beijing Novartis Pharma Co. Ltd.

Jian Kang

PhD
First Hospital of China Medical University;Institute of Respiratory Disease, First Hospital of China Medical University

Changzheng Wang

PhD
Xinqiao Hospital, Third Military Medical University

Michael Humphries

MD
Beijing Novartis Pharma Co. Ltd.

Ioannis Kottakis

MD
Novartis Pharma AG

Jing Li

PhD
Guangzhou Medical University

Nanshan Zhong

MD, FCCP
Guangzhou Medical University;National Clinical Research Centre for Respiratory Diseases, First Affiliated Hospital of Guangzhou M;State Key Lab of Respiratory Disease, National Clinical Research Cente

Robert Fogel

MD
Novartis Pharmaceuticals Corporation

Sophia Wang

MD
China Novartis Institutes for Biomedical Research Co., Ltd.

Clinical Efficacy of Omalizumab, as Measured by Patient-Reported Outcomes, in Chinese Patients with Moderate or Severe Allergic Asthma